The FDA seeks applications to maintain and manage existing research consortia established by the Critical Path Institute to foster drug innovation and development.
FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.
NIH's limited competition supports partnerships between resource-limited institutions and designated cancer centers to strengthen cancer research, infrastructure, training, and outreach.
PCORI's Implementation Awards -- Cycle 1 2027 funds projects to put patient-centered CER results into practice, spread evidence, and plan for future implementation in real-world healthcare.
This grant supports centers at institutions with strong existing research in NIDDK-related diseases, funding shared resources, collaboration, mentoring, and pilot programs to advance research in areas like diabetes, obesity, and liver diseases.
Funds a Clinical Coordinating Center to lead multi-site clinical trials using innovative designs, focusing on NHLBI’s mission and health outcome disparities.